For any enquiry about our products, please phone us on +34 917 991 564 |info@finabiotech.es

Blog Medium Image

/Blog Medium Image
Blog Medium Image2019-01-18T15:46:43+01:00

Recent presentations of UROBEST in international meetings

Press release March 8th, 2017 RECENT PRESENTATIONS OF UROBEST IN INTERNATIONAL MEETINGS UROBEST has been presented in both the 23rd Meeting of the EAU Section of Urological Research (ESUR) held in October 20th- 22nd, 2016 in Parma, Italy and in the 14th meeting of the International Bladder Cancer Network (IBCN), held in October 27th- 29th, 2016 in Bochum, Germany. Dr. [...]

By |marzo 10th, 2017|Categories: Finabiotech News|0 Comments

Biofina Diagnostics S.L. attends BIOSPAIN 2016

Biofina Diagnostics S.L. has recently attended BIOSPAIN2016, the 8th edition of the International Meeting on Biotechnology which took place in Bilbao (Spain) from the 28th to 30th of September. BIOSPAIN is the largest European biotech event organized by a national bioindustry association (ASEBIO) and one of the largest in the world by the number of one-to-one meetings and companies participating. [...]

By |octubre 5th, 2016|Categories: Finabiotech News|0 Comments

Biofina Diagnostics S.L has recently attended the 111th American Urological Association’s Annual Meeting (AUA2016) held in San Diego, California, from the 6th until the 10th of May.

Press release May 18th, 2016 Biofina Diagnostics S.L has recently attended the 111th American Urological Association's Annual Meeting (AUA2016) held in San Diego, California, from the 6th until the 10th of May. Dr. Mengual has presented a poster titled “Prospective, blinded, international and multicenter validation of a gene expression test for the non-invasive diagnosis of bladder cancer”. This poster includes performance [...]

By |mayo 18th, 2016|Categories: Finabiotech News|0 Comments

Dr. Maria J. Ribal participates in the AUA 2016

Dr. Maria J. Ribal has participated in a Plenary session titled “Complex cases in Bladder Cancer: High Grade Superficial TCAA When There Is No BCG o BCG Fails” during the 111th American Urological Association's Annual Meeting (AUA2016) held at the Convention Center in San Diego, California, from the 6th until the 10th of May. She has discussed with a panel [...]

By |mayo 18th, 2016|Categories: Finabiotech News|0 Comments

Press release – Biofina Diagnostics S.L will be attending the 111th American Urological Association’s Annual Meeting to be held in San Diego, California, from the 6th until the 10th of May.

Biofina Diagnostics S.L will be attending the 111th American Urological Association's Annual Meeting to be held in San Diego, California, from the 6th until the 10th of May. Dr. Mengual will present a poster titled “Prospective, blinded, international and multicenter validation of a gene expression test for the non-invasive diagnosis of bladder cancer”. This poster includes performance results of a [...]

By |abril 1st, 2016|Categories: Finabiotech News|0 Comments

Press release – Biofina Diagnostics announces two patents were granted in the U.S. and in Canada, from family “BLADDER CANCER DIAGNOSIS AND/OR PROGNOSIS METHOD”.

Biofina Diagnostics announces that two new patents have been granted in 2015 in the United States and in Canada, both belonging to the patent family “BLADDER CANCER DIAGNOSIS AND/OR PROGNOSIS METHOD”. In the United States the patent 9,097,715 has been granted by the United States Patent and Trademark Office (USPTO). The Patent Term Adjustment determined by the USPTO is 1,289 [...]

By |febrero 11th, 2016|Categories: Finabiotech News|0 Comments